In addition, there was no statistically significant difference in withdrawal due to adverse events: 21MMF/SRL (14%) vs 10 MMF/CNI (7%).

• 此外，因为不良反应而停止这方面也没有统计上的显著差异：21例MMF/SRL(14%25) 、MMF/CNI则是10例(7%25)；